201. A functional SNP upstream of the ADRB2 gene is associated with COPD
- Author
-
Li Yu, Jin-Xiu Li, Ya-Ping Zhang, Lu-Ming Dai, Xiao-Hua Zhang, Jing Zhang, Wei-Ping Fu, Chang Sun, and Li Zhong
- Subjects
0301 basic medicine ,medicine.medical_specialty ,COPD ,business.industry ,Single-nucleotide polymorphism ,General Medicine ,medicine.disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Endocrinology ,030228 respiratory system ,Polymorphism (computer science) ,Internal medicine ,medicine ,SNP ,Allele ,business ,Chromatin immunoprecipitation ,Genotyping ,Transcription factor - Abstract
Background Previous studies have suggested that β2-adrenergic receptor (ADRB2) is associated with COPD. However, the role of genetic polymorphisms in ADRB2 on COPD has not been evaluated yet. Methods In this study, SNaPshot genotyping, luciferase assay, chromatin immunoprecipitation and real-time polymerase chain reaction were adopted to investigate the association between ADRB2 genetic polymorphisms and COPD, comprehensively. Results One single nucleotide polymorphism (rs12654778), located upstream of ADRB2, showed a significant association with COPD by the logistic regression analysis after adjusting for age, sex and smoking history (p=0.04) in 200 COPD patients and 222 controls from southwest Chinese population. Furthermore, the luciferase assay indicated that rs12654778-A allele reduced the relative promoter activity by ~26% compared with rs12654778-G allele (p=0.0034). The chromatin immunoprecipitation analysis demonstrated that rs12654778 modulated the binding affinity of transcription factor neurofibromin 1. In addition, a significantly reduced expression of ADRB2 in COPD patients was observed, compared with normal controls (p=0.017). Conclusion Our findings suggest a previously unknown mechanism linking allele-specific effects of rs12654778 on ADRB2 expression to COPD onset, for the first time.
- Published
- 2018